BIRAC BIG: A Complete Guide to the Biotechnology Ignition Grant
ZeedFund Team on 1 September 2026
Biotechnology is a uniquely unforgiving field for early stage innovation. Ideas that could genuinely change lives, a faster diagnostic test, an affordable therapeutic, a sustainable agricultural input, often need years of validation before they resemble anything close to a fundable product. Traditional investors rarely have the patience or the technical depth to back a biotech idea at its earliest, most uncertain stage, leaving many of India's most promising scientist entrepreneurs stuck exactly where their work matters most.
The Biotechnology Ignition Grant (BIG) is the flagship early stage scheme of the Biotechnology Industry Research Assistance Council (BIRAC), a not for profit enterprise set up by the Department of Biotechnology (DBT), Government of India. BIG exists on a simple but powerful belief: that India's real bio innovation capital comes from the countless novel ideas emerging from research institutes, academia, and startups, ideas that need funding and mentorship long before they are ready for the market. Rather than waiting for these ideas to mature elsewhere, BIG steps in early, bridging the gap between scientific discovery and genuine commercial invention.
The Funding Opportunity: What BIRAC BIG Actually Offers
- Grant amount up to Rs. 50 lakh, provided as grant in aid, with no repayment required since this is non dilutive funding.
- Duration: support is extended over a maximum period of 18 months.
- Disbursement: funds are released in milestone based installments rather than as a single upfront payment, keeping progress tied to genuine, demonstrable results.
- Beyond the money: every BIG grantee is paired with mentoring, monitoring, and business development support through BIRAC's network of BIG Partner institutions across the country.
Who is eligible
- Applicant must be an Indian citizen, and must be physically incubated in an incubator, any bio incubator, whether or not it is BIRAC supported.
- Eligible entities include individual scientist entrepreneurs, early stage startups, and researchers with a registered company and a functional R&D laboratory.
- For registered companies or LLPs, the startup age allowed under BIG, for entities incorporated on or after August 1, 2021, is capped at 5 years.
- The project must focus on high level biotech innovation with genuine commercialization potential. BIG is explicitly not intended for basic research projects.
- Prior recipients of a BIG grant are generally ineligible to apply again.
How the process works
- Calls for BIG proposals are typically issued twice a year, opening around January 1 and July 1, and remaining open for roughly 45 days.
- Register as a BIG User on the official BIRAC website and submit your proposal online. Physical or hard copy submissions are not accepted.
- Your proposal is reviewed by BIRAC's technical evaluation committees for scientific merit and commercial potential.
- If selected, you are paired with a BIG Partner institution, who manages mentoring, monitoring, and milestone based fund disbursement over the 18 month grant period.
Since call windows are time limited and specific eligibility details are revised periodically, always check the current call guidelines on BIRAC's official website before preparing your application.
The Institutions Powering BIRAC BIG
BIG is implemented through a network of BIG Partner institutions spread across India, each responsible for mentoring and monitoring the grantees assigned to them. Grantees themselves are free to choose any bio incubator, whether or not it is BIRAC supported, to house their actual project work, giving founders real flexibility in where they base their research. A few institutions running BIG include:
Live Funding Opportunities
BIRAC also maintains a broader network of BioNEST supported bio incubators nationally, which frequently serve as the physical home for BIG funded projects even when the formal BIG Partner is a different institution.
BIRAC's Impact So Far
BIG has now run through more than 25 call cycles since launch, a sign of a program that has stayed twice yearly and continuous for over a decade. Its network of BIG Partner institutions includes established names like the Centre for Cellular and Molecular Platforms in Bangalore, the Foundation for Innovation and Technology Transfer in New Delhi, IKP Knowledge Park in Hyderabad, Venture Center in Pune, and the SIDBI Innovation and Incubation Centre at IIT Kanpur, among others.
Zooming out to BIRAC as a whole, the parent organization behind BIG, DBT BIRAC reports having extended roughly Rs. 4,200 crore in funding support across more than 15 lakh startups, entrepreneurs, and innovators, catalyzing an estimated Rs. 7,000 crore in total downstream investment, supporting the development of over 900 products, and helping create more than 35,000 skilled jobs across its full portfolio of schemes, of which BIG is the earliest stage entry point.
Frequently Asked Questions
Do I need a registered company to apply for BIG?
Not necessarily. Individual innovators and scientist entrepreneurs can apply, provided they are physically incubated at a bio incubator. Registered companies and LLPs with a functional R&D lab are also eligible, subject to the startup age cap.
Is BIG funding a loan?
No. BIG is a grant in aid. There is no repayment obligation, and it does not require giving up equity in your company.
How is BIG different from BIRAC's SEED Fund?
BIG funds the earliest stage, idea validation and proof of concept. The SEED Fund, by contrast, is for startups that have already passed proof of concept and need capital assistance to become investment ready for angel or venture capital.
Can I apply for BIG more than once?
No. Prior recipients of a BIG grant are generally not eligible to apply for it again, since the scheme is designed specifically for first time, early stage validation.
The Bottom Line
BIG remains one of the most accessible entry points into India's biotech funding ecosystem, genuinely built for the scientist or early founder with a promising idea and no track record yet to point to. For biotech innovators sitting on research with real commercial potential but no way to fund the crucial proof of concept stage, BIG offers both the capital and the structured mentorship needed to take that first credible step forward.